137 related articles for article (PubMed ID: 37329807)
1. 15-deoxy-Δ
Li W; Xie J; Yang L; Yang Y; Yang L; Li L
Int Immunopharmacol; 2023 Aug; 121():110491. PubMed ID: 37329807
[TBL] [Abstract][Full Text] [Related]
2. miR-27b-3p, miR-181a-1-3p, and miR-326-5p are involved in the inhibition of macrophage activation in chronic liver injury.
Li W; Chang N; Tian L; Yang J; Ji X; Xie J; Yang L; Li L
J Mol Med (Berl); 2017 Oct; 95(10):1091-1105. PubMed ID: 28748390
[TBL] [Abstract][Full Text] [Related]
3. Effect of 15-Deoxy-△(12,14)-prostaglandin J2 on Expression of Macrophage Migration Inhibitory Factor in Mouse Monocyte/macrophage Cell Line J774A.1.
Li WY; Shi YM; Liu X; Yang L; L I LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):247-52. PubMed ID: 27544994
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Δ
Chen K; Li JJ; Li SN; Feng J; Liu T; Wang F; Dai WQ; Xia YJ; Lu J; Zhou YQ; Guo CY
Acta Pharmacol Sin; 2017 May; 38(5):672-687. PubMed ID: 28216619
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Δ
Takagi T; Naito Y; Mizushima K; Hirai Y; Kamada K; Uchiyama K; Handa O; Ishikawa T; Itoh Y
Arch Biochem Biophys; 2019 Nov; 677():108183. PubMed ID: 31704099
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-Δ(12,14)-Prostaglandin J2 Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway.
Liu X; Jia S; Li W; Yang L; Yang L; Wang L; Li L
PPAR Res; 2015; 2015():876160. PubMed ID: 26457076
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
8. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
[TBL] [Abstract][Full Text] [Related]
9. [Effect of 15-deoxy-Δ(12), 14-prostaglandin J2 on the cytokines in the culture supernatant of bone marrow mesenchymal stem cells].
Chi Y; DU WJ; Cui JJ; Chen F; Han ZB; Ma FX; Li X; Yang SG; Lu SH; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1557-62. PubMed ID: 24370048
[TBL] [Abstract][Full Text] [Related]
10. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model.
Monroy MA; Opperman KK; Pucciarelli M; Yerrum S; Berg DA; Daly JM
Shock; 2007 Aug; 28(2):186-91. PubMed ID: 17510607
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
12. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
14. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
Ye F; Sun T; Luo H; Ding H; Chen K; Shen X; Jiang H
Cell Physiol Biochem; 2006; 18(1-3):143-50. PubMed ID: 16914899
[TBL] [Abstract][Full Text] [Related]
15. 15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating HO-1 and reducing hepatic cell autophagy.
Chen K; Li J; Li S; Feng J; Wu L; Liu T; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Wang F; Dai W; Xia Y; Lu J; Zhou Y; Guo C
Biomed Pharmacother; 2016 May; 80():183-192. PubMed ID: 27133055
[TBL] [Abstract][Full Text] [Related]
16. 15-Deoxy-Δ
Yamamoto Y; Koma H; Yagami T
Biol Pharm Bull; 2020; 43(1):153-157. PubMed ID: 31902920
[TBL] [Abstract][Full Text] [Related]
17. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
19. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ ameliorates endotoxin-induced acute lung injury in rats.
Liu D; Geng Z; Zhu W; Wang H; Chen Y; Liang J
Chin Med J (Engl); 2014; 127(5):815-20. PubMed ID: 24571868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]